We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Depomed, Inc. (Nasdaq: DEPO) and Madaus S.r.l. today announced that the companies have entered into a distribution and supply agreement for ProQuin(R) XR, Depomed's once-daily, extended release formulation of the antibiotic ciprofloxacin.
Official data suggests that Israel's exports of hi-tech goods declined by 3% in the third quarter of 2005 to US$3.86bn, but external sales of pharmaceuticals soared 19% in the three-month period.
According to Russia's State Statistics Committee, consumer prices for pharmaceuticals in the country increased by just 0.3% in October, while core inflation increased 0.6% in the month.
IDM Pharma said Friday it is selling its infectious disease treatment technology to Danish drug maker Pharmexa A/S for $12 million so IDM can concentrate on its five clinical-stage cancer programs, as well as reduce its cash burn and increase its cash position.
Daiichi Sankyo announced on November 25 that its wholly owned subsidiaries Sankyo and Daiichi Pharmaceutical have agreed to establish a new company, Daiichi Sankyo Healthcare Co., Ltd., as of December 15.
Genosis plc, a U.K. company focusing on consumer products for reproductive health, Monday announces a successful fund raising and confirmation of its proposed admission to AIM with dealings expected on Dec. 2. Genosis said it's raising GBP7.0 million before expenses through a placing of 6,363,634 shares at 110 pence per share which have been placed with institutional and other investors.
Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma") and Neurobiological Technologies, Inc. (NASDAQ:NTII) ("NTI") today announce the close of Celtic Pharma's acquisition of exclusive worldwide rights to XERECEPT(R), a Phase III clinical compound for the treatment for Peritumoral Brain Edema.
Hungary's leading drugs producer Richter Gedeon and Forest Laboratories have entered into two new collaborations for CNS (central nervous system) compounds.